NCT02351999 Clinical Study of the TSP Crosser System for Transseptal Access and Left Atrial Catheter Navigation Status COMPLETED Phase NA
NCT02348723 Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) Status COMPLETED Phase PHASE4
NCT02347111 Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation Status RECRUITING Phase PHASE4
NCT02345356 A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics Status COMPLETED Phase N/A
NCT02341105 AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation Status TERMINATED Phase PHASE4
NCT02339493 Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter Status COMPLETED Phase NA
NCT02334254 Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Status UNKNOWN Phase PHASE4
NCT02332096 Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation Status COMPLETED Phase N/A
NCT02325778 Comparison of CTI Ablation Prior to or After LA Ablation for AF Status COMPLETED Phase PHASE3
NCT02317029 Comparison of Oxygen Interventions and Defibrillator Efficiency Status TERMINATED Phase NA
NCT02313584 Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk Status UNKNOWN Phase PHASE3